Pharma And Life Science Outsourcing Europe Companies - Top Pharma And Life Science Outsourcing Consulting Service Companies In Europe
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

1MED: Dynamic And Proactive CRO for Clinical And Regulatory Development
line

Top 10 Pharma and Life Science Outsourcing Consulting/Service Companies in Europe - 2020

line

The advent of rapid technological innovations and efficient services has led to new possibilities in the pharma and life sciences industry. More firms today aim to innovate faster while keeping the resource requirement in check by using cloud technology solutions.

Using the current technologies, outsourcing partners in the pharma and life science industry are bringing game-changing improvements in almost every aspect of the operations, from process execution to resource management. The skilled and experienced workers of these partner firms provide subject matter expertise that allows pharma companies to handle complex situations. They also guide their clients’ teams to make the most of the technology solutions for maximum results. So pharma companies can cater to the rising market demands quickly and cost-efficiently.

Currently, the pharma and life science firms are under tremendous pressure as the COVID-19 pandemic continues to wreak havoc across communities globally. It has become necessary for them to quickly develop and supply an effective vaccine for COVID-19. In such a scenario, pharma companies need to build stronger relationships with their outsourcing partners and fuel innovation for a quick breakthrough. This at a time when the pandemic has forced the global workforce to execute tasks remotely.

Amid these trends, which are playing a crucial role in the pharma and life sciences sector, Pharma Tech Outlook has compiled a list of top 10 pharma and life science outsourcing consulting/services companies in Europe. Backed by their unique capabilities, these companies exhibit competence in delivering efficient services to the pharma and life sciences industry. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your firm need to improve project outcomes and accelerate innovation.

We present to you Pharma Tech Outlook’s “Top 10 Pharma and Life Science Outsourcing Consulting/Services Companies in Europe – 2020.”

    Top Pharma and Life Science Outsourcing Consulting/Service Companies in Europe

  • 1MED is a Contract Research Organization providing regulatory strategy, clinical trial management and quality assurance services to the medical device and pharmaceutical industry. The company is an ISO 13485:2016 certified Company particularly active in the medical devices’ field, specialized both on technological and substance-based medical devices, including combination products (drug-device). The company not only offers a broad range of internal competences and clients can also trust on a preferred partners network and consolidated relationships with European Notified Bodies and Competent Authorities

    1med.ch

  • CABB manufactures high-quality primary products, intermediate products, and active ingredients in fine chemistry for organisations in agrochemical, pharmaceutical and specialty chemical industries. The company’s vision is to handle complex chemistry more reliably, sustainably, and efficiently, making them the preferred partner and world market leader in complex fine chemistry. CABB is a leading manufacturer of chlorination and sulfonation reagents such as thionyl chloride, sulfuryl chloride, oleum, chlorosulfonic acid and sulfur trioxide complexes. The product portfolio also includes the subsequent downstream chemistry and products such as monochloroacetic acid and its derivatives, acid chlorides, chlorides, and sulfonic acid derivatives. The uniqueness of CABB is that it is the only fine chemicals custom manufacturing specialist with a transatlantic production footprint in Switzerland, Finland and the U.S

    cabb-chemicals.com

  • EirGenix is a contract development and manufacturing organisation that provides high-quality and cost-effective services. The company was founded on the grounds of leveraging a dual business model that follows the principles of internal product development of biologics and a biologics-based CDMO. EirGenix excels in developing monoclonal antibodies (mAb), bispecific mAbs, fusion proteins, recombinant proteins, protein vaccines, and plasmid DNAs. EirGenix provides full-scope services from cell line development and process optimisation to small-scale and commercial good manufacturing practices (GMP) certified services for both mammalian and microbial cell-based biologics. Depending on a client’s needs, the company creates a study plan by leveraging its staff’s vast experiences and has additionally developed a proprietary CHO K-1 cell line with exceptional titer performance

    www.eirgenix.com

  • A global CRO Monitoring Force challenges the misconception that “a CRO has to be large to be good” by taking a zealous approach to complete projects on time and on budget. Monitoring Force extends end-to-end support, from drug development to regulatory approval. It offers concept evaluation as well as clinical trial development and management services that take the heavy lifting off the clients’ shoulders. Nimble and agile, the CRO seeks to find the best solutions to clients’ unique needs by customizing its services. It also offers patient-friendly medical writing service to present medical evidence to patients, allowing them to become more aware and responsible toward their health

    monitoringforcegroup.com

  • Aenova Group

    Aenova Group

    The Aenova Group is one of the world's leading companies in the pharmaceutical and healthcare industry. Competence and experience are the keys to their success. With innovative technologies and the highest quality standards, the company is a reliable partner to the pharmaceutical and healthcare industry

  • Fermion

    Fermion

    Fermion develops, manufactures and markets active pharmaceutical ingredients (APIs) to companies in global generic market as well as under exclusive contracts to companies focusing on new chemical entities (NCEs). The company's product portfolio consists of over 30 generic APIs and over 10 NCEs. Fermion is a fully owned subsidiary of Orion Corporation and headquartered in Espoo, Finland

  • numerus

    numerus

    Numerus is a niche clinical research organisation (CRO) providing analytical expertise to the drug development industry with a proven track record in clinical trials, a specialised skillset for health technology assessment, and innovative capabilities in applying statistics and epidemiology to real world data

  • Olon Spa

    Olon Spa

    OLON is an italian company world leader in the Active Pharmaceutical Ingredients (APIs) production, using synthetic and biological processes for Generic market as well as in Contract Development and Manufacturing (CDMO). The company offers complete integrated packages and services to support the full development of APIs based on strong knowledge in both Chemical and Biological process, all of them under a full cGMP and regulatory coverage

  • Pharmatest Services

    Pharmatest Services

    Pharmatest Services (Pharmatest) is a preclinical contract research organization offering translational research services for diseases with unmet clinical needs. They offer full-service research solutions for early drug development. The company's focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models

  • TransCure bioServices

    TransCure bioServices

    TransCure offers pre-clinical contract research services to pharmaceutical, biotech, start-up and academic researchers who need faster, smarter and cost-effective solutions for drug profiling. Uniquely designed animal models with functional humanized systems have been developed to provide predictive in vivo pharmacology testing in the field of inflammation, and autoimmune (IBD, RA, SLE, MS), anti-infective (HIV, EBV, CMV, Dengue), vaccine development, biosimilar and preclinical lead candidate selection/validation for drug development